Document Detail


The clofibrate saga: a retrospective commentary.
MedLine Citation:
PMID:  22486628     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Michael Oliver
Related Documents :
17965288 - Redox-dependent coronary metabolic dilation.
8633948 - Hyperkalemia alters endothelium-dependent relaxation through non-nitric oxide and noncy...
2896488 - Comparative study of direct coronary vascular responses to diltiazem, adrenergic beta-b...
11045968 - Effect of sildenafil on coronary active and reactive hyperemia.
696648 - Relation of lipids, weight and physical activity to incidence of coronary heart disease...
17188668 - Surgical animal models of heart failure related to coronary heart disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  74     ISSN:  1365-2125     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-13     Completed Date:  2013-04-16     Revised Date:  2013-12-06    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  907-10     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticholesteremic Agents / adverse effects,  therapeutic use*
Clinical Trials as Topic
Clofibrate / adverse effects,  therapeutic use*
Coronary Disease / mortality,  prevention & control*
Gallstones / chemically induced
Humans
Hypolipidemic Agents / adverse effects,  therapeutic use*
Male
Chemical
Reg. No./Substance:
0/Anticholesteremic Agents; 0/Hypolipidemic Agents; HPN91K7FU3/Clofibrate
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oral health status in elders from South Brazil: a population-based study.
Next Document:  Meta-analysis: vasoactive medications for the management of acute variceal bleeds.